Risk Factors Associated with Cervical Cancer Among Patients at Parirenyatwa Hospital in 2023

Abstract

Globally, cervical cancer is still a major health concern, especially in low- and middle income nations. The purpose of this study was to determine and examine the risk factors for cervical cancer in patients treated at Parirenyatwa Hospital in 2023. Comprehending these risk variables is essential to developing successful preventative measures and enhancing the prognosis for cervical cancer. Thirty individuals with cervical cancer were involved in a retrospective case-control study and medical records served as a means of data collection. According to preliminary research, there are a number of important risk factors for cervical cancer at Parirenyatwa Hospital in 2023. Among them were HIV, tobacco usage, low socioeconomic status, multiple sexual partners, human papillomavirus (HPV) infection, and low socioeconomic status. According to the results of the logistic regression analysis, the biggest predictor of cervical cancer was HIV.This research adds to the body of knowledge by offering insightful information about the particular risk factors linked to cervical cancer at Parirenyatwa in 2023. The findings highlight the necessity of comprehensive programs aimed at reducing these risk factors and enhancing cervical cancer prevention, diagnosis, and treatment results in the area. For the purpose of effectively controlling cervical cancer, more research is necessary to investigate new variables and improve preventive measures. This study has implications for future avenues in research as well as for clinical practice and public health policies. HIV has been found to be a significant predictor, which emphasizes the urgent need for integrated approaches to cervical cancer and HIV therapy. Improving access to healthcare services, raising public awareness, and bolstering screening initiatives are critical first steps in lowering the incidence of cervical cancer in the study group and beyond. In summary, the risk factors for cervical cancer among patients treated at Parirenyatwa Hospital in 2023 are clarified by this dissertation. The results highlight the significance of all-encompassing treatments that improve cervical cancer prevention, and treatment outcomes by focusing on the identified risk factors. In order to better understand the etiology of cervical cancer and create global strategies for combating the disease, research efforts must continue